ORG 2766

Drug Profile

ORG 2766

Latest Information Update: 08 Jan 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Organon
  • Developer Nonindustrial source; Organon
  • Class Anterior pituitary hormones; Hypothalamic hormones; Peptide fragments
  • Mechanism of Action Adenylate cyclase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Autistic disorder; Dementia; Diabetic neuropathies; Neurological disorders

Most Recent Events

  • 08 Jan 2001 Discontinued - Unspecified in Anxiety disorders in Netherlands (PO)
  • 08 Jan 2001 Discontinued - Unspecified in Autism in Netherlands (PO)
  • 03 Feb 1997 Discontinued-III for Dementia in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top